PubMed · 15780617
Novel heterocyclic thyromimetics.
Abstract
Novel heterocycle-fused thyromimetics are presented carrying indoles or indazoles instead of the phenolic group in T3. Potent agonists were identified in both series. SAR trends are examined and found to be mostly consistent with previously published thyromimetics. Moderate THRbeta selectivity (approx. 10-fold) was observed in the indole series using isoform-selective transient THR transfection assays.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Helmut Haning, Michael Woltering, Ulrich Mueller, Gunter Schmidt, Carsten Schmeck, Verena Voehringer, Axel Kretschmer, Josef Pernerstorfer. 2005-04-01. Novel heterocyclic thyromimetics.. https://doi.org/10.1016/j.bmcl.2005.02.028
Cite the original work for its findings. Save a collection to share your selection of sources.